RecruitingNot ApplicableNCT06251323

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)


Sponsor

Stanford University

Enrollment

119,680 participants

Start Date

Sep 30, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in qualitative interviews. Patient HbA1c data from the clinics will be collected for comparative data analysis during each year of the study.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing a team-based, technology-supported care model to improve blood sugar control for adults with type 2 diabetes at community health clinics serving low-income patients. This is a clinic-level study — it is aimed at federally qualified health centers (FQHCs), not individual patients directly. You may be eligible (as a clinic) if: your clinic is one of the two largest sites at a multi-clinic FQHC in Massachusetts, Ohio, California, or Puerto Rico; and your clinic is in the lower half of A1c control performance. You may NOT be eligible if: more than 80% of your patients are children; your diabetes patient volume is in the lowest 10%; or your total patient count is under 5,000 or over 50,000. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERiPATH implementation approach

A multi-level, multi-component, customized, standardized, technology enabled, person-centered, and team-based care practice transformation strategy.


Locations(4)

Board of Trustees of the Leland Stanford Junior University

Stanford, California, United States

President and Fellows of Harvard College, T.H. Chan School

Boston, Massachusetts, United States

The Ohio State University

Columbus, Ohio, United States

Impactivo, LLC.

San Juan, Puerto Rico, Puerto Rico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06251323


Related Trials